Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXMust be obtained within 14 days prior to registration for protocol therapy: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000 mm^3, must be obtained within 8 weeks prior to screening for protocol therapyXx_NEWLINE_xXELIGIBILITY CRITERIA FOR RANDOMIZATION (STEP 1): Platelets > 100,000 mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3 must be obtained =< 7 days prior to protocol registrationXx_NEWLINE_xXPlatelets >= 100,000/mcL within 28 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXWithin 2 weeks prior to registration: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3 within 4 weeks prior to randomizationXx_NEWLINE_xXPlatelets >= 100,000/mcL, obtained within 28 days prior to step 2 registrationXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXWithin 60 days prior to registration on study: Platelets >= 100,000/mm^3Xx_NEWLINE_xXWithin 14 days prior to registration: Platelets >= 100,000/mclXx_NEWLINE_xXWithin less than or equal to 14 days prior to registration: Platelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mm^3, equivalent to CTCAE v 3.0 grade 0-1Xx_NEWLINE_xXPlatelets >= 100,000/mcL within 4 weeks before randomizationXx_NEWLINE_xXPlatelets >= 100,000 cell/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/L within 14 days prior to registration.Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3, within 21 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 documented within 28 days prior to step 1 registrationXx_NEWLINE_xXPlatelets > 100,000/mcl documented within 28 days prior to step 3 registrationXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100,000/ mm3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000Xx_NEWLINE_xXplatelets ?100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/L.Xx_NEWLINE_xXPlatelets >= 100 x 10^9/L (for treatment phase)Xx_NEWLINE_xXMeasured within 28 days prior to registration: platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >/= 100 × 109/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcl obtained within 14 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100,000/mcL within 14 days of registrationXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets ? 100 × 109/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXSAFETY RUN-IN: Within 10 days of registration: Platelets >= 100,000 / mcLXx_NEWLINE_xXRANDOMIZED PHASE II CLINICAL TRIAL: Within 10 days of registration: Platelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets ? 100,000/mLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets ? 100,000/mm3;Xx_NEWLINE_xXPlatelets ?100 x 109/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets ? 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 × 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcL (>= 100,000/mm^3)Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets ?100,000/mm3;Xx_NEWLINE_xXPlatelets >= 100,000/mm^3, within 14 days before the first dose of cabozantinibXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (PLT) >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXENDOCRINE RESISTANT AND ADJUVANT COHORT: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets greater than or equal to 100,000/mclXx_NEWLINE_xXPlatelets =< 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets (PLT) >= 100,000 obtained =< 14 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/mm^3 within 7 days before the first dose of cabozantinibXx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL.Xx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100,000/mcLXx_NEWLINE_xXPlatelets ? 100,000 /mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ?100,000 ?L.Xx_NEWLINE_xXObtained within 21 days prior to study registration: platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcL.Xx_NEWLINE_xXPlatelets ?100 × 10?9/L;Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets ?100,000/mm^3 (?100 × 10^9/L);Xx_NEWLINE_xXENROLLMENT TO THE DOSE ESCALATION, EXPANSION AND PART II: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3 or >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXplatelets: ? 100 x 109/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXObtained =< 2 weeks prior to registration: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets < 100,000/µLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/microliters, completed within 14 days prior to the date of registrationXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 K/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3 obtained within 30 days prior to registrationXx_NEWLINE_xXPlatelets greater than or equal to 100,000/mcl, within 14 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/L, determined within 14 days of registrationXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXWithin 28 days of study registration: Platelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets: > 100,000/mcLXx_NEWLINE_xXARM 2 - A: Platelets: >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^2 (100 x 10^9/L)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ?100×109/L (w/o transfusions w/in 21 days)Xx_NEWLINE_xXPlatelets ?100,000/mcL (non-transfused platelet count)Xx_NEWLINE_xXCOHORT I: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL (not requiring platelet transfusions)Xx_NEWLINE_xXPlatelets <100 x 109/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets less than 100,000/cubic mmXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100,000/mm^3.Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > = 100,000 cells/mm3.Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 K/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm3.Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets < 100,000 per mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 × 10^9/L.Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL.Xx_NEWLINE_xXPlatelets >= 100,000/mcL, =< 5 days prior to C1D1Xx_NEWLINE_xXPlatelets >= 100,000/mcL.Xx_NEWLINE_xXARM I&II: Platelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets ? 100,000 cells/mm^3Xx_NEWLINE_xXObtained within 28 days prior to registration: Platelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXWithin 28 days prior to registration: Platelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 K/mm^3Xx_NEWLINE_xXPlatelets ? 100 x 109/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets* ? 100,000/mm³ (? 100 x 10^9/L)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/dlXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXObtained within 28 days prior to registration: platelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets (PLT) ? 100Xx_NEWLINE_xXObtained within 28 days prior to the first dose of cabozantinib: platelets >= 100,000/mm^3.Xx_NEWLINE_xXWithin 4 weeks of day 1: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL.Xx_NEWLINE_xXPlatelets (plt) >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100 K/mm^3.Xx_NEWLINE_xXPlatelets >= 100,000 x 10^9 /LXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3 within 14 days of study registrationXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL.Xx_NEWLINE_xXPlatelets >= 100,000 / mcL.Xx_NEWLINE_xXWithin 7 days of registration: Platelets >= 100,000/mcLXx_NEWLINE_xXWithin 10 days prior to on-study date: Platelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 k/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (Plt) >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXWithin 14 days of the first dose of study drug: Platelets >= 100,000/·LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/L (For patients with hepatocellular carcinoma, platelets >= 70 x 10^9/L).Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXWithin 7 days before the first dose of study treatment: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/ mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3, at the time of enrollmentXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets < 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL within 30 days of registrationXx_NEWLINE_xXPlatelets ? 100,000/?L without transfusion support within 28 days prior to study treatmentXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcL 14 days or fewer from registrationXx_NEWLINE_xXPlatelets ?100,000/mm^3 (?100 × 10^9/Liters [L])Xx_NEWLINE_xXPlatelets (plts) > 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets > 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100 x 10^9/L without transfusionXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xX(For both cohorts A and B): Platelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXWithin 4 weeks prior to the registration: platelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXWithin 28 days prior to registration for protocol therapy: Platelets >= 100,000 K/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3 OR >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100,000/mm^3, within 28 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/mcL (with or without transfusion)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mL.Xx_NEWLINE_xXPlatelets < 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 /mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mlXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000 /mcL in the absence of transfusion support within 7 days of determining eligibilityXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (no transfusion within prior 7 days) >= 100 K/cu mmXx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcL, assessed within 14 days prior to registrationXx_NEWLINE_xXPlatelets ? 100,000 cells/mm3;Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > = 100 000 mcLXx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXPlatelets >= 100,000 /mcLXx_NEWLINE_xXPlatelets >= 100,000 /mcL.Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 k/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets ? 100 × 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL, during screening and on cycle 1, day 1Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets < 100 x 10^9 /LXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets < 100 x 10^9/L (100,000 per mm^3)Xx_NEWLINE_xXObtained within 14 days prior to registration; platelets ?100,000 cells/mm^3Xx_NEWLINE_xXPlatelets < 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mcl, regardless of transfusion or growth factor supportXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets: >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcL (not requiring platelet transfusions)Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100,000/?LXx_NEWLINE_xXPlatelets >= 100,000/mcL within 14 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3, within 14 day prior to registrationXx_NEWLINE_xXWithin 14 days prior to registration: Platelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPHASE I: Platelets >= 100,000/mcL without growth factor supportXx_NEWLINE_xXPHASE II SCLC: Platelets >= 100,000/mcL without growth factor supportXx_NEWLINE_xXPlatelets > 100 K/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL (transfusion independent, defined as not receiving platelet transfusions within 7 days prior to laboratory sample)Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000Xx_NEWLINE_xXPlatelets ? 100,000/mm^3 (100 x 10^9/L)Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100 x 109 cells/LXx_NEWLINE_xXPlatelets of 100,000 per mcL or moreXx_NEWLINE_xXPlatelets: >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100 x 109/L.Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcL (without transfusion within 2 weeks prior to cycle 1, day 1)Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXREGORAFENIB INCLUSION CRITERIA: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/µLXx_NEWLINE_xXPHASE I: Platelets > 100,000/mclXx_NEWLINE_xXPHASE II: Platelets > 100,000/mclXx_NEWLINE_xXWithin 14 days prior to registration: Platelets >= 100,000 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcL except in cases of marrow infiltration by lymphomaXx_NEWLINE_xXPlatelets ? 100,000/?lXx_NEWLINE_xXWithin 14 days of first dose of study drug administration: Platelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets greater than or equal to 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets < 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (Plts) >= 100 k/mm^3Xx_NEWLINE_xXPlatelets ?100,000/mm^3 (?100x10^9/L)Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcL (transfusion not permitted)Xx_NEWLINE_xXPlatelets >= 100,000 /mcLXx_NEWLINE_xXWithin 6 weeks of day 1: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100 x 10^9/L within 14 days of study entryXx_NEWLINE_xXPlatelets >= 100,000/mm^2 (100 x 10^9/L)Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets < 100,000/ mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/ mcLXx_NEWLINE_xXPlatelets >= 100,000/?L without transfusion support within the past 28 daysXx_NEWLINE_xXPlatelets >= 100 K/cu mmXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 /mcLXx_NEWLINE_xXPlatelets > 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets < 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3 (may not be transfused to meet this level for enrollment)Xx_NEWLINE_xXPlatelets >= 100,000 per mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL, determined within 14 days of registrationXx_NEWLINE_xXPlatelets <100 x 109/LXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000 cells/mm^3Xx_NEWLINE_xXWithin 4 days prior to the first dose of cabozantinib: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/L, obtained within 30 days of study registrationXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3 (SI units 100 x 10^9/L)Xx_NEWLINE_xXPlatelets > 100,000 mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/dlXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXplatelets ? 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100 x 10^9/LXx_NEWLINE_xXPlatelets < 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets < 100,000/mm3Xx_NEWLINE_xXWithin 14 days prior to registration: Platelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/µLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3 (transfusion independent)Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets < 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets > 100,000/mcl (unless secondary to MCL)Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^9/L (transfusion dependent)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXWithin 4 weeks of preregistration: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 microliter (transfusion independent)Xx_NEWLINE_xXPlatelets >= 100 K/mcLXx_NEWLINE_xXPlatelets < 100,000/mm3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 mm^3Xx_NEWLINE_xXPlatelets >= 100,000/cu mmXx_NEWLINE_xXPlatelets >= 100,000 mm^3Xx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets < 100,000/mm^3Xx_NEWLINE_xXPlatelets > 100,000Xx_NEWLINE_xXPlatelets >= 100 x 10^3/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^3/mm^3Xx_NEWLINE_xXPlatelets ? 100 x 109/LXx_NEWLINE_xXPlatelets ? 100,000/µLXx_NEWLINE_xXplatelets ? 100,000/?L,Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100 K/ mm^3Xx_NEWLINE_xXPlatelets ? 100,000/µL (?100 x 10^9/L)Xx_NEWLINE_xXPlatelets <100 X 109/LXx_NEWLINE_xXPlatelets ? 100,000/?LXx_NEWLINE_xXPlatelets>100,000/mm3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (PLT) >= 100,000Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 100/LXx_NEWLINE_xXPlatelets ? 100 x 109/LXx_NEWLINE_xXplatelets greater than or equal to 100,000 cells/microliterXx_NEWLINE_xXPlatelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000.Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXWithin 14 days of first dose of study drug: Platelets > 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets (PLT) >= 100 x 10^9/L without transfusionsXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100,000/microliter without transfusion and/or growth factors in the 3 months prior to randomizationXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXRENAL COHORT: Laboratory values as follows within 4 days before the first dose of daratumumab: platelets ? 100,000/mm^3Xx_NEWLINE_xXBLADDER: Clinical laboratory values at screening: platelets ? 100,000/mm^3Xx_NEWLINE_xXWithin 7 days before the first dose of cabozantinib: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 × 10^9/L =< 14 days prior to registrationXx_NEWLINE_xXPlatelets ? 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets (no transfusion within prior 7 days) >= 100 K/cu mmXx_NEWLINE_xXPlatelets >= 100,000Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets are 100,000/mm3Xx_NEWLINE_xXBlood counts performed within 3 weeks prior to starting study therapy must have platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9 / LXx_NEWLINE_xXPlatelets ? 100,000/mm^3 (? 21days [d] of study day 1)Xx_NEWLINE_xXPlatelets >= 100,000/ mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100 K/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^3/mm^3Xx_NEWLINE_xXWithin 14 days prior to step 1 registration: Platelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets: >= 100,000 / mm^3Xx_NEWLINE_xXPlatelets count >= 100,000 cells/mm^3, obtained within 14 days prior to registration for protocol therapyXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXDOSE ESCALATION COHORT: Platelets ? 100,000/mcLXx_NEWLINE_xXDOSE EXPANSION COHORT: Platelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXWithin 28 days prior to administration of therapy: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/ mm^3 (transfusion independent)Xx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 per mm^3Xx_NEWLINE_xXPlatelets >= 100,000 /mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXWithin 14 days of registration: Platelets >= 100,000/mcL unsupported by transfusionsXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL (without transfusion)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 × 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 × 10^9/LXx_NEWLINE_xXPlatelets count > 100,000 mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3 (untransfused)Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3, within 14 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPHASE II: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/L, within 2 weeks of the first dose of study treatmentXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets of 100,000 per mcL or moreXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets of 100,000 per mcL or moreXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPHASE II: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >=100,000/mcLXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcL assessed within seven (7) days prior to the start of therapyXx_NEWLINE_xXPlatelets >=100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mlXx_NEWLINE_xXPlatelets greater than or equal to 100,000/mm^3Xx_NEWLINE_xXPlatelets > 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets > 100 x 10^9/L without transfusionXx_NEWLINE_xXPlatelets ?100,000/mm^3 (?100 x 10^9/L)Xx_NEWLINE_xXPlatelets >= 100,000/mcL; these results must be obtained within 28 days prior to registrationXx_NEWLINE_xXPlatelets greater than or equal to 100,000/mm^3 (CTCAE grade 0-1)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets greater than or equal to 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000 mcL be obtained within 42 days prior to registrationXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets (plt) ? 100 x 109/L,Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000 mm^3Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets greater than or equal to 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXREGISTRATION #2 - PRIOR TO CONSOLIDATION CHEMOTHERAPY: Platelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/L.Xx_NEWLINE_xXPlatelets greater than or equal to 100,000/mcL (platelets >= 100 x 10^9/L)Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXWithin 14 days prior to registration: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (PLT) >= 100,000Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets (PLT) >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 /mcLXx_NEWLINE_xXPlatelets ?100,000/mm3 (?100 × 109/L) without platelet transfusion for 7 daysXx_NEWLINE_xXPlatelets ? 100,000 cells/ml,Xx_NEWLINE_xXPlatelets >100,000/mL (without platelet transfusion within the last 2 weeks)Xx_NEWLINE_xXPlatelets ? 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3 within 14 days prior to study registrationXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100,000 cells/mm3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (plt) ? 100 x 109/L.Xx_NEWLINE_xXPlatelets (Plt) ?100 x 109/L.Xx_NEWLINE_xXPlatelets >= 100,000/ mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/lXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ?100,000/?LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ?100,000 / mLXx_NEWLINE_xXWithin 14 days of study start: Platelets (plt) >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000 /mcLXx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets greater than or equal to 100,000 cells/mclXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL within 14 days prior to Step 3 registrationXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000 per mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9 (SI units 10^9/L)Xx_NEWLINE_xXPlatelets >= 100,000/LXx_NEWLINE_xXPlatelets > 100,000/?LXx_NEWLINE_xXPlatelets >= 100,000/mm^3 (100 x 10^9/L) (unless due to marrow involvement) obtained within 4 weeks prior to registrationXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXWithin 14 days of enrollment: Platelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3 (within 14 days prior to day 1 of protocol therapy)Xx_NEWLINE_xXPlatelets* ? 100,000/mm3 (? 100 x 109/L)Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets of > 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ?100,000/?L (?150,000/?L, if within 12 weeks of prior nitrosourea treatment).Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/L.Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000Xx_NEWLINE_xXWithin 14 days prior to registration: platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100 k without transfusion support in the past 28 daysXx_NEWLINE_xXPlatelets >= 100,000/mcL, within 14 days of study registrationXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (PLT) >= 100,000/mm^3Xx_NEWLINE_xXPlatelets (Plt) > 100Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100 x 10^9 cells/LXx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXObtained within 14 weeks prior to registration on study: platelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/L obtained within 14 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL at all times during the screening period without platelet transfusion within 3 weeksXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (plt) >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets ? 100 x 10?/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL (transfusion independent, defined as not receiving platelet transfusions within a 7-day period prior to enrollment)Xx_NEWLINE_xXPlatelets greater than or equal to 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/?LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3 based on CBC/differential obtained within 21 days prior to study registrationXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets>=100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 /mm^3; previous transfusion is allowedXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets greater than 100,000/mcLXx_NEWLINE_xXPlatelets ?100,000/?LXx_NEWLINE_xXWithin 14 days of registration: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPHASE I: Platelets >= 100,000/mcLXx_NEWLINE_xXPHASE II: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets ?100 x 10^9/L.Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 X 10^9 cells/LXx_NEWLINE_xXPlatelets ? 100,000/µLXx_NEWLINE_xXPlatelets >= 100,000 mlXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3 within 4 weeks of enrollmentXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3 within 30 days prior to registrationXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPART B: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets (plt) >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcl (must be within 7 days of MLA)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 K/mcLXx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets > 100,000/µLXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (plt) >= 100 x 10^9/LXx_NEWLINE_xXPlatelets ? 100 x 10^9/LXx_NEWLINE_xXREGISTRATION INCLUSION CRITERIA: Platelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100 x 10^9/L.Xx_NEWLINE_xXPlatelets >= 100,000 mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 per mm^3Xx_NEWLINE_xXObtained =< 7 days prior to registration: Platelets (PLT) >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets>= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets > 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets ? 100 x 109/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 K/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXplatelets >100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3 (transfusion independent)Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000Xx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXPlatelets (PLT) >= 100 x 10^9/L (>= 100,000/mm^3) may be supported by transfusion and/or hematopoetic growth factorsXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000/mLXx_NEWLINE_xXPlatelets >= 100 x 10^9/L (without transfusion < 14 days before enrollment)Xx_NEWLINE_xXWithin 14 days prior to registration: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets <100,000/mm3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100 KXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9 cells/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/?LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000Xx_NEWLINE_xXCARBOPLATIN AND PACLITAXEL ARMS: platelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXEXPANSION COHORT ONLY: Platelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcL (transfusion independent) within two weeks prior to enrollmentXx_NEWLINE_xXPlatelets < 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXWithin 8 weeks of randomization: Platelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 /mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets greater than or equal to 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXplatelets >100,000/mm3Xx_NEWLINE_xXPlatelets (PLT) > 100,000/mlXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (PLT) >= 100 x 10^9/L without transfusionsXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets < 100,000/mlXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets < 100 x 109/LXx_NEWLINE_xXPlatelets >= 100,000mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets: >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ?100,000/?LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets>= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets (PLT) >= 100,000Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/L; (100,000/mm^3)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100,000//microLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100,000/µL (? 100 x 103/µL)Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets ?100,000/?L;Xx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXSELUMETINIB ARM: Platelets < 100 x 10^9/L (100,000 per mm^3)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/microlitersXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^3/mm; may not be reached by transfusionXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/ mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100 × 10³/µLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000Xx_NEWLINE_xXPlatelets (plt) >= 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets ? 100,000/mclXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets ? 100 × 109/L;Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100,000 cells/mm3.Xx_NEWLINE_xXPlatelets < 100,000/mm3Xx_NEWLINE_xXPlatelets > 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets ? 100 x 10^9, Hb ? 90 g/L, ANC ? 1.5 x 10^9/L.Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (PLT) >= 100,000/mcLXx_NEWLINE_xXAbsolute neutrophil count (ANC) ? 1,000/?L, platelets ? 100,000/?L.Xx_NEWLINE_xXPlatelets (PLT) >= 100 x 10^9/L without transfusionsXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets (PLT) >= 100,000/?L obtained =< 7 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXAnemia (hemoglobin <11 mg/dL) or thrombocytopenia (platelets<100,000/?L).Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 K/mcLXx_NEWLINE_xXPlatelets (PLT) >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets ? 100,000/µLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/?LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mm^3 (unsupported)Xx_NEWLINE_xXPlatelets >= 100,000/µLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >100,000/µlXx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 X 10^9/LXx_NEWLINE_xXHematology WBC <4,000 mm3 Platelets <100,000 mm3Xx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mcL (within four weeks prior to the study)Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets (PLT) >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets < 100 x 10^9/LXx_NEWLINE_xXPlatelets > 100,000/mlXx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3 (SI units 100 x 10^9/L)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets count > 100,000 mm^3 and less than 1,000,000 mm^3Xx_NEWLINE_xXPlatelets greater than or equal to 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets < 100 K/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/mcL within 28 days prior to registrationXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcL, independent of transfusions/growth factors within 3 months of treatment startXx_NEWLINE_xXWithin 30 days of surgery: Platelets >= 100,000/mlXx_NEWLINE_xXPlatelets >= 100,000 cells/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000Xx_NEWLINE_xXPlatelets > 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets: >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mlXx_NEWLINE_xXPlatelets >= 100,000/ml (within 30 days of surgery)Xx_NEWLINE_xXPlatelets >= 100,000/mcL within 28 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000 cells/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100,000 mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100,000/microliterXx_NEWLINE_xXPlatelets >= 100 B/L (10^9/L)Xx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100,000/ mm3Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets ? 100 x 109/LXx_NEWLINE_xXPlatelets ? 100,000/mm3 (untransfused [> 5 days] without growth factors)Xx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100 x 109/LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXWithin 14 days prior to study entry: Platelets > 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 75,000/mcL for bevacizumab monotherapy cohort; > 100,000/mcL for bevacizumab + lomustine cohortXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXAt the discretion of the operating surgeon, platelets > 100,000/mclXx_NEWLINE_xXAt the discretion of the physician, platelets > 100,000/mclXx_NEWLINE_xXPlatelets >= 100 X 10^9/L (evaluated within 28 days of randomization)Xx_NEWLINE_xXPlatelets >= 100,000/mclXx_NEWLINE_xXPlatelets >= 100 K/cu mmXx_NEWLINE_xXPlatelets >= 100 K/cu mmXx_NEWLINE_xXPlatelets >= 100,000/mcL (within 14 days of study registration)Xx_NEWLINE_xXPlatelets ? 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 / mcL, obtained =< 30 days prior to registrationXx_NEWLINE_xXPlatelets >= 100,000/L, within 2 weeks prior to study startXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets < 100,000/?LXx_NEWLINE_xXPlatelets >= 100,000/mm^3Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100 x 10^9/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ? 100 x 10E9/LXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets > 100,000/mcLXx_NEWLINE_xXPlatelets > 100 x 109/L,Xx_NEWLINE_xXPlatelets ?100 x 109/LXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets ?100,000/mm3 (?100 × 109/L)Xx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXPlatelets >= 100,000 / mcLXx_NEWLINE_xXPlatelets >= 100,000/mcLXx_NEWLINE_xXplatelets ? 100,000/mm3,Xx_NEWLINE_xXPlatelets >= 100,000 /mcLXx_NEWLINE_xX